Drug Trial Radar · NCT03304379
Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
Last checked: Nov 19, 2026Latest source record: Feb 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,650
Actual
Start
Oct 26, 2017
Primary completion
Dec 13, 2019
Study completion Nov 9, 2020
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- Collaborators
- Teva Pharmaceutical Industries, Ltd.
- First posted
- Oct 9, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the efficacy of fasinumab compared to placebo, when administered for up to 24 weeks in patients with pain due to osteoarthritis (OA) of the knee or hip. The secondary objectives of the study are: * To evaluate the efficacy of fasinumab compared to non-steroidal anti-inflammatory drugs (NSAID)s, when administered for up to 24 weeks in patients with pain due to OA of the knee or hip * To assess the safety and tolerability of fasinumab compared to placebo and compared to NSAIDs, when administered for up to 24 weeks in patients with pain due to OA of the knee or hip
Conditions
- Osteoarthritis, Knee
- Osteoarthritis, Hip
Interventions
FasinumabDrug
Solution for injection in pre-filled syringe
DiclofenacOther
NSAID active comparator (capsule)
CelecoxibOther
NSAID active comparator (capsule)
Matching placeboDrug
Fasinumab-matching placebo (solution for injection in pre-filled syringe); NSAID-matching placebo (capsule)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Scores up to Week 24 in Participants Treated With Fasinumab Compared to PlaceboTime frame: Baseline up to Week 24
- Change From Baseline in WOMAC Physical Function Subscale Scores up to Week 24 in Participants Treated With Fasinumab Compared to PlaceboTime frame: Baseline up to Week 24
Locations
71 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, Llc
Anniston, Alabama
Horizon Research Partners
Mobile, Alabama
Clinical Research Advantage, Inc./Warner Family Practice, PC
Chandler, Arizona
Synexus Central Phoenix Medical Clinic
Phoenix, Arizona
Clinical Research Consortium Arizona
Tempe, Arizona
Advance Research Center
Anaheim, California
TriWest Research Associates, LLC
El Cajon, California
Paragon Rx Clinical Research, Inc.
Garden Grove, California
Catalina Research Institute, LLC
Montclair, California
Sierra Clinical Research
Roseville, California
UC Davis Center for Musculoskeletal Health
Sacramento, California
Advanced Research Center, Inc
San Diego, California
California Research Foundation
San Diego, California
Paragon Rx Clinical Research, Inc
Santa Ana, California
Encompass Clinical Research
Spring Valley, California
Westlake Medical Research
Thousand Oaks, California
Synexus Clinical Research US, Inc.
Vista, California
Mountain View Clinical Research
Denver, Colorado
New England Research Associates, LLC
Bridgeport, Connecticut
CRM of Greater New Haven, LLC
Hamden, Connecticut
Stamford Therapeutics Consortium
Stamford, Connecticut
Avail Clinical Research, LLC
DeLand, Florida
AMB Research Center, Inc
Miami, Florida
Allied Biomedical Research Institute
Miami, Florida
Lakes Research, LLC
Miami Lakes, Florida
Bioclinica Research
Orlando, Florida
Gulf Region Clinical Research institute
Pensacola, Florida
Integral Rheumatology & Immunology Specialists (IRIS)
Plantation, Florida
Progressive Medical Research
Port Orange, Florida
Drug Studies America
Marietta, Georgia
Georgia Institute For Clinical Research LLC
Marietta, Georgia
North Georgia Clinical Research
Woodstock, Georgia
Chicago Clinical Research Institute, Inc
Chicago, Illinois
Affinity Clinical Research Institute
Oak Lawn, Illinois
Clinical Research Advantage, Inc.
Evansville, Indiana
MediSphere Medical Research Center, LLC
Evansville, Indiana
L-MARC Research Center
Louisville, Kentucky
Tandem Clinical Research
Marrero, Louisiana
Tufts Medical Center, Inc.
Boston, Massachusetts
Great Lakes Research Group, Inc.
Bay City, Michigan
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.